Subscribe

Archive | Cannabis Science Inc

Cannabis Science Inc. Releases Corporate Operational Guidance for 2013

CannabisScience

COLORADO SPRINGS, Colo., Jan. 31, 2013 /PRNewswire/ — Cannabis Science, Inc. (NASD OTC: CBIS) announced today itsCorporate Operational Guidance for 2013, highlighting a strategic action plan to “bring to market” innovative, cannabinoid-based, life-saving, anti-cancer drugs.  The Company anticipates releasing a variety of cannabinoid-based treatments that already show great promise in fighting HIV-related illnesses like Kaposi’s […]

Cannabis Science May Unlock the Future of Biotech and Medicine

gw_pharmaceuticals

NEW YORK, January 23, 2013 /PRNewswire/ — At the forefront of revolutionary medicine, Cannabis Science, Inc. (CBIS) [Full Research Report][1] has been heavily investing in the research and development of cannabis, otherwise known as marijuana. With focus on utilizing the medicinal use of marijuana, Cannabis Science is looking to bring medical treatments to areas such as […]

Phytiva Reveals Details of Hemp-Based Product Line-Up

phytiva

Phytiva Reveals Detailed Information About Its Hemp-Based Product Line to be Released in 2013 in Retail Operations with Its Initial, Primary Focus on North American and European Markets. (via PR Newswire) DALLAS, Dec. 19, 2012 /PRNewswire/ — X-Change Corp. (NASD OTC: XCHC), a U.S. boutique company in the cosmeceutical, nutraceutical, and cardiovascular health industries, is proud […]

X-Change Corp. Acquires Both the Cannabis Science “Phytiva” Brand and the Cannabis Science Joint Venture with Dupetit Natural Products, GmbH, Based in Germany

gw_pharmaceuticals

X-Change Corp. Acquires Both the Cannabis Science “Phytiva” Brand and the Cannabis Science Joint Venture with Dupetit Natural Products, GmbH, Based in Germany (via PR Newswire) DALLAS, Dec. 13, 2012 /PRNewswire/ — X-Change Corporation (NASDAQ OTC: XCHC), a U.S. publicly-traded company has acquired both the Cannabis Science, Inc. (NASDAQ OTC: CBIS) “Phytiva” Brand of products, including […]

Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board

Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board

Cannabis Science Appoints Dr. Michael J. Goldblatt, the Former Director of Defense Sciences at the Defense Advanced Research Projects Agency (DARPA), to its Scientific Advisory Board (via PR Newswire) COLORADO SPRINGS, Colo., Nov. 26, 2012 /PRNewswire/ — Cannabis Science, Inc. (NASD OTC: CBIS) has appointed Michael J. Goldblatt, Ph.D., the former Director of Defense Sciences […]